Nyxoah (Nasdaq:NYXH) announced today that it received FDA approval for its Genio neuromodulation device for treating sleep apnea.

NanoVibronix (Nasdaq:NAOV) today announced that it intends to effect a reverse stock split of its common stock.

Gentuity announced that it entered into an agreement with GE HealthCare to collaborate on commercial activities for imaging ...

Medtronic Diabetes today offered a sneak peek at the new Abbott sensor technology specifically designed for its MiniMed ...

The FDA has issued an early communication to warn of updated instructions for use for certain Boston Scientific Watchman access systems.

The FDA approved the protocol update, significantly expanding patient eligibility criteria for enrollment in the study.